WO2012089465A3 - Verwendung von 13-hydroxy-9,11- octadecadiensäure zur bräunung menschlicher haut, zur färbung menschlicher haare und zur behandlung von polymorpher lichtdermatose - Google Patents

Verwendung von 13-hydroxy-9,11- octadecadiensäure zur bräunung menschlicher haut, zur färbung menschlicher haare und zur behandlung von polymorpher lichtdermatose Download PDF

Info

Publication number
WO2012089465A3
WO2012089465A3 PCT/EP2011/072033 EP2011072033W WO2012089465A3 WO 2012089465 A3 WO2012089465 A3 WO 2012089465A3 EP 2011072033 W EP2011072033 W EP 2011072033W WO 2012089465 A3 WO2012089465 A3 WO 2012089465A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxy
treating
octadecadienoic acid
tanning
human skin
Prior art date
Application number
PCT/EP2011/072033
Other languages
English (en)
French (fr)
Other versions
WO2012089465A2 (de
Inventor
Mike Farwick
Tim KÖHLER
Original Assignee
Evonik Goldschmidt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Goldschmidt Gmbh filed Critical Evonik Goldschmidt Gmbh
Priority to CN2011800634444A priority Critical patent/CN103282017A/zh
Priority to EP11794127.8A priority patent/EP2658512A2/de
Priority to US13/976,204 priority patent/US20130315849A1/en
Publication of WO2012089465A2 publication Critical patent/WO2012089465A2/de
Publication of WO2012089465A3 publication Critical patent/WO2012089465A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair

Abstract

Gegenstand der Erfindung ist die Verwendung von 13-Hydroxy-9,11-octadecadiensäure zur Bräunung menschlicher Haut und damit assoziierter Verfahren.
PCT/EP2011/072033 2010-12-30 2011-12-07 Verwendung von 13-hydroxy-9,11-octadecadiensäure zur bräunung menschlicher haut WO2012089465A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN2011800634444A CN103282017A (zh) 2010-12-30 2011-12-07 13-羟基-9,11-十八碳二烯酸用于美黑人类皮肤、用于对人类毛发染色以及用于治疗多形性光皮肤病的用途
EP11794127.8A EP2658512A2 (de) 2010-12-30 2011-12-07 Verwendung von 13-hydroxy-9,11-octadecadiensäure zur bräunung menschlicher haut, zur färbung menschlicher haare und zur behandlung von polymorpher lichtdermatose
US13/976,204 US20130315849A1 (en) 2010-12-30 2011-12-12 Use of 13-hydroxy-9,11-octadecadienoic acid for tanning human skin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010056550A DE102010056550A1 (de) 2010-12-30 2010-12-30 Verwendung von 13-Hydroxy-9, 11-octadecadiensäure zur Bräunung menschlicher Haut
DE102010056550.4 2010-12-30

Publications (2)

Publication Number Publication Date
WO2012089465A2 WO2012089465A2 (de) 2012-07-05
WO2012089465A3 true WO2012089465A3 (de) 2013-05-23

Family

ID=45315785

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/072033 WO2012089465A2 (de) 2010-12-30 2011-12-07 Verwendung von 13-hydroxy-9,11-octadecadiensäure zur bräunung menschlicher haut

Country Status (5)

Country Link
US (1) US20130315849A1 (de)
EP (1) EP2658512A2 (de)
CN (1) CN103282017A (de)
DE (1) DE102010056550A1 (de)
WO (1) WO2012089465A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4060040A1 (de) * 2014-01-24 2022-09-21 Kyoto University Verfahren zur herstellung einer seltenen fettsäure mittels neuartigem enzym und neuartige seltene fettsäure
CN110831570B (zh) 2017-07-06 2022-10-18 帝斯曼知识产权资产管理有限公司 新用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097059A2 (de) * 1982-06-16 1983-12-28 Unilever N.V. Hautbehandlungsmittel
WO1998021948A1 (en) * 1996-11-19 1998-05-28 E-L Management Corporation Self tanning compositions containing dha and alpha hydroxy acids
DE10133197A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
US20050063930A1 (en) * 1998-03-06 2005-03-24 Anders Carlsson Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001031506A (ja) * 1999-07-22 2001-02-06 Gekkeikan Sake Co Ltd 天然物由来抗菌剤
AU2003271049A1 (en) 2002-10-15 2004-05-04 L'oreal Use of amide or ester of sugar and of fatty acid, for treating and/or preventing dry skin
DE102008001788A1 (de) 2008-05-15 2009-11-26 Evonik Goldschmidt Gmbh Verwendung organomodifizierter Siloxanblockcopolymere zur Herstellung kosmetischer oder pharmazeutischer Zusammensetzungen
US20090317341A1 (en) 2008-06-18 2009-12-24 Conopco, Inc., D/B/A Unilever Compositions for Lightening Skin Color

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0097059A2 (de) * 1982-06-16 1983-12-28 Unilever N.V. Hautbehandlungsmittel
WO1998021948A1 (en) * 1996-11-19 1998-05-28 E-L Management Corporation Self tanning compositions containing dha and alpha hydroxy acids
US20050063930A1 (en) * 1998-03-06 2005-03-24 Anders Carlsson Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
DE10133197A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Aminosäuren enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut

Also Published As

Publication number Publication date
WO2012089465A2 (de) 2012-07-05
CN103282017A (zh) 2013-09-04
US20130315849A1 (en) 2013-11-28
EP2658512A2 (de) 2013-11-06
DE102010056550A1 (de) 2012-07-05

Similar Documents

Publication Publication Date Title
IN2015DN02938A (de)
HK1207330A1 (en) Topical dermal formulations and methods of personalized treatment of skin
EP2755721A4 (de) System und verfahren zur behandlung der haut und darunterliegendem gewebe für verbesserte gesundheit, funktion und/oder verbessertes erscheinungsbild
GB201307157D0 (en) Biophotonic compositions, kits and methods
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
WO2013138374A3 (en) Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
PT2848097T (pt) Dispositivo para o tratamento de plasma de superfícies humanas, animais ou de plantas, em particular da pele ou de áreas de membrana mucosa
MX2013006595A (es) Tratamiento de lesion de la medula espinal y lesion traumatica del cerebro empleando celulas madre placentarias.
EP2610779A4 (de) Verfahren und system zur identifikation menschlicher gesichter sowie infrarot-gegenlichtkompensationsverfahren und -system
ZA201208413B (en) Skin treatment composition
EP2654745A4 (de) Zusammensetzung zur behandlung von hautleiden
WO2013174774A3 (en) Cosmetic compositions comprising magnetosomes and uses thereof
UA105405C2 (ru) Гуманизированное антитело против человеческого il-22ra
WO2012076109A3 (de) 2-pyrone
EP2729156A4 (de) Verfahren und zusammensetzungen zur behandlung der fitzpatrick-hauttypen iv, v und vi
MX367393B (es) Composiciones antifungicas para el tratamiento de piel y uñas.
BR112013002043A2 (pt) composição de tratamento de pele, método de clareamento de pele e uso
WO2014044602A3 (de) Mittel zum behandeln keratinischer fasern, enthaltend spezifische aminosilikone, säuren und direktziehende farbstoffe
PL2758383T3 (pl) Preparaty kosmetyczne lub dermatologiczne zawierające amidotiazole aromatyczne i ich stosowanie do usuwania niepożądanych przebarwień skóry i zapobiegania ich powstawaniu
EA201170672A1 (ru) Соединения, пригодные для лечения целлюлита
GB201107350D0 (en) Topical treatment of skin infection
MX2021010546A (es) Composiciones y metodos para tratamiento de la piel.
PL2643486T3 (pl) Przyrząd do obróbki i/lub garbowania skór lub tekstyliów
WO2013059233A3 (en) Thermoresponsive compositions for dermatological use and methods thereof
PL2758382T3 (pl) Preparaty kosmetyczne lub dermatologiczne zawierające aminotiazole heterocyklokarbonylowe i ich stosowanie do usuwania niepożądanych przebarwień skóry i zapobiegania ich powstawaniu

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11794127

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2011794127

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 13976204

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE